Protective human monoclonal antibodies target conserved sites of vulnerability on the underside of influenza virus neuraminidase

被引:4
|
作者
Lederhofer, Julia [1 ]
Tsybovsky, Yaroslav [2 ]
Nguyen, Lam [1 ]
Raab, Julie E. [1 ]
Creanga, Adrian [1 ]
Stephens, Tyler [2 ]
Gillespie, Rebecca A. [1 ]
Syeda, Hubza Z. [1 ]
Fisher, Brian E. [1 ]
Skertic, Michelle [1 ]
Yap, Christina [1 ]
Schaub, Andrew J. [1 ]
Rawi, Reda [1 ]
Kwong, Peter D. [1 ]
Graham, Barney S. [1 ,5 ]
Mcdermott, Adrian B. [1 ,6 ]
Andrews, Sarah F. [1 ]
King, Neil P. [3 ,4 ]
Kanekiyo, Masaru [1 ]
机构
[1] Natl Inst Allergy & Infect Dis, Vaccine Res Ctr, NIH, Bethesda, MD 20892 USA
[2] Natl Canc Inst, Vaccine Res Ctr Electron Microscopy Unit, Canc Res Technol Program, Frederick Natl Lab Canc Res, Frederick, MD 21702 USA
[3] Univ Washington, Dept Biochem, Seattle, WA 98195 USA
[4] Univ Washington, Inst Prot Design, Seattle, WA 98195 USA
[5] Morehouse Sch Med, Atlanta, GA 30310 USA
[6] Sanofi, F-69007 Lyon, France
关键词
Protective antigenic site; HEMAGGLUTININ-NEURAMINIDASE; ACTIVE-SITE; VALIDATION; INFECTION; ANTIGENICITY; EVOLUTION; TOOLS; CELLS;
D O I
10.1016/j.immuni.2024.02.003
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Continuously evolving influenza viruses cause seasonal epidemics and pose global pandemic threats. Although viral neuraminidase (NA) is an effective drug and vaccine target, our understanding of the NA antigenic landscape still remains incomplete. Here, we describe NA -specific human antibodies that target the underside of the NA globular head domain, inhibit viral propagation of a wide range of human H3N2, swine -origin variant H3N2, and H2N2 viruses, and confer both pre- and post -exposure protection against lethal H3N2 infection in mice. Cryo-EM structures of two such antibodies in complex with NA reveal non -overlapping epitopes covering the underside of the NA head. These sites are highly conserved among N2 NAs yet inaccessible unless the NA head tilts or dissociates. Our findings help guide the development of effective countermeasures against ever-changing influenza viruses by identifying hidden conserved sites of vulnerability on the NA underside.
引用
收藏
页码:574 / 586.e7
页数:21
相关论文
共 50 条
  • [21] Broadly protective bispecific antibodies that simultaneously target influenza virus hemagglutinin and neuraminidase (vol 15,e01085-24,2024)
    Ramos, Kevin E.
    Okba, Nisreen M. A.
    Tan, Jessica
    Bandawane, Pooja
    Meade, Philip
    Loganathan, Madhumathi
    Francis, Benjamin
    Shulenin, Sergey
    Holtsberg, Frederick W.
    Aman, M. Javad
    Mcmahon, Meagan
    Krammer, Florian
    Lai, Jonathan R.
    MBIO, 2025,
  • [22] Location of antigenic sites recognized by monoclonal antibodies in the influenza A virus nucleoprotein molecule
    Varich, Natalia L.
    Kochergin-Nikitsky, Konstantin S.
    Usachev, Evgeny V.
    Usacheva, Olga V.
    Prilipov, Alexei G.
    Webster, Robert G.
    Kaverin, Nikolai V.
    JOURNAL OF GENERAL VIROLOGY, 2009, 90 : 1730 - 1733
  • [23] INFLUENZA-VIRUS NEURAMINIDASE - STRUCTURE, ANTIBODIES, AND INHIBITORS
    COLMAN, PM
    PROTEIN SCIENCE, 1994, 3 (10) : 1687 - 1696
  • [24] Influenza virus neuraminidase (NA): a target for antivirals and vaccines
    Anitha Jagadesh
    Abdul Ajees Abdul Salam
    Piya Paul Mudgal
    Govindakarnavar Arunkumar
    Archives of Virology, 2016, 161 : 2087 - 2094
  • [25] Influenza virus neuraminidase (NA): a target for antivirals and vaccines
    Jagadesh, Anitha
    Salam, Abdul Ajees Abdul
    Mudgal, Piya Paul
    Arunkumar, Govindakarnavar
    ARCHIVES OF VIROLOGY, 2016, 161 (08) : 2087 - 2094
  • [26] ANTIGENIC AND BIOLOGICAL CHARACTERIZATION OF INFLUENZA-VIRUS NEURAMINIDASE (N2) WITH MONOCLONAL-ANTIBODIES
    WEBSTER, RG
    BROWN, LE
    LAVER, WG
    VIROLOGY, 1984, 135 (01) : 30 - 42
  • [27] Human antibodies reveal a protective epitope that is highly conserved among human and nonhuman influenza A viruses
    Grandea, Andres G., III
    Olsen, Ole A.
    Cox, Thomas C.
    Renshaw, Mark
    Hammond, Philip W.
    Chan-Hui, Po-Ying
    Mitcham, Jennifer L.
    Cieplak, Witold
    Stewart, Shaun M.
    Grantham, Michael L.
    Pekosz, Andrew
    Kiso, Maki
    Shinya, Kyoko
    Hatta, Masato
    Kawaoka, Yoshihiro
    Moyle, Matthew
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2010, 107 (28) : 12658 - 12663
  • [28] Human Monoclonal Antibodies Broadly Neutralizing against Influenza B Virus
    Yasugi, Mayo
    Kubota-Koketsu, Ritsuko
    Yamashita, Akifumi
    Kawashita, Norihito
    Du, Anariwa
    Sasaki, Tadahiro
    Nishimura, Mitsuhiro
    Misaki, Ryo
    Kuhara, Motoki
    Boonsathorn, Naphatsawan
    Fujiyama, Kazuhito
    Okuno, Yoshinobu
    Nakaya, Takaaki
    Ikuta, Kazuyoshi
    PLOS PATHOGENS, 2013, 9 (02)
  • [29] Protective human antibodies against a conserved epitope in pre- and postfusion influenza hemagglutinin
    Finney, Joel
    Moseman, Annie Park
    Kong, Susan
    Watanabe, Akiko
    Song, Shengli
    Walsh Jr, Richard M.
    Kuraoka, Masayuki
    Kotaki, Ryutaro
    Moseman, E. Ashley
    Mccarthy, Kevin R.
    Liao, Dongmei
    Liang, Xiaoe
    Nie, Xiaoyan
    Lavidor, Olivia
    Abbott, Richard
    Harrison, Stephen C.
    Kelsoe, Garnett
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2024, 121 (01)
  • [30] A neutralizing-protective supersite of human monoclonal antibodies for fever virus
    Li, Yan
    Chen, Zhihai
    Wu, Lili
    Dai, Lianpan
    Qi, Jianxun
    Chai, Yan
    Li, Shihua
    Wang, Qihui
    Tong, Zhou
    Ma, Sufang
    Duan, Xiaomin
    Ren, Shuning
    Song, Rui
    Liang, Mifang
    Liu, Wenjun
    Yan, Jinghua
    Gao, George F.
    INNOVATION, 2022, 3 (06):